HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ludwig Kiesel Selected Research

Hormones (Hormone)

1/2023Progesterone from ovulatory menstrual cycles is an important cause of breast cancer.
10/2022Anti-Hormonal Therapy in Breast Cancer and Its Effect on the Blood-Brain Barrier.
11/2021Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21WAF1/CIP1.
6/2021Perimenopause and Postmenopause - Diagnosis and Interventions. Guideline of the DGGG and OEGGG (S3-Level, AWMF Registry Number 015-062, September 2020).
6/2021Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide.
5/2021Hormone Replacement Therapy After Gynaecological Malignancies: a Review Article.
1/2021Prognostic significance of hedgehog signaling network-related gene expression in breast cancer patients.
1/2020The Heparan Sulfate Sulfotransferases HS2ST1 and HS3ST2 Are Novel Regulators of Breast Cancer Stem-Cell Properties.
12/2013Genomic profiling in triple-negative breast cancer.
1/2013Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ludwig Kiesel Research Topics

Disease

43Breast Neoplasms (Breast Cancer)
06/2023 - 07/2003
35Neoplasms (Cancer)
04/2024 - 07/2003
11Endometriosis
03/2022 - 12/2003
10Triple Negative Breast Neoplasms
09/2023 - 01/2011
7Neoplasm Metastasis (Metastasis)
10/2022 - 04/2016
5Noninfiltrating Intraductal Carcinoma (DCIS)
01/2023 - 10/2004
5Carcinogenesis
01/2021 - 04/2004
4Inflammation (Inflammations)
04/2024 - 04/2009
4Endometrial Neoplasms (Endometrial Cancer)
08/2023 - 10/2011
4Ovarian Neoplasms (Ovarian Cancer)
06/2023 - 05/2021
4Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2022 - 05/2021
4Carcinoma (Carcinomatosis)
01/2022 - 01/2006
4Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2022 - 10/2007
3Cardiovascular Diseases (Cardiovascular Disease)
06/2021 - 05/2020
3Osteoporosis
06/2021 - 04/2016
3Leiomyoma (Uterine Fibroids)
07/2011 - 02/2009
2Spontaneous Abortion (Miscarriage)
01/2022 - 01/2018
2Ovarian Hyperstimulation Syndrome
01/2022 - 01/2018
2Dyslipidemias (Dyslipidemia)
05/2020 - 02/2009
2Psychological Sexual Dysfunctions (Sexual Arousal Disorder)
05/2020 - 11/2009
2Hyperplasia
02/2015 - 10/2007
2Infertility (Sterility)
07/2011 - 10/2007
2Obesity
12/2009 - 02/2009
2Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos)
04/2008 - 07/2006
2Breast Diseases (Breast Disease)
10/2007 - 04/2004
1Hot Flashes
06/2023
1Brain Neoplasms (Brain Tumor)
10/2022
1Serous Cystadenocarcinoma
05/2022
1Necrosis
03/2022

Drug/Important Bio-Agent (IBA)

13Syndecan-1 (Syndecan 1)IBA
06/2023 - 01/2006
12Hormones (Hormone)IBA
01/2023 - 12/2003
10Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
06/2023 - 04/2009
9Estrogens (Estrogen)FDA Link
01/2023 - 07/2003
8MicroRNAs (MicroRNA)IBA
04/2024 - 09/2012
7Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 07/2003
6Small Interfering RNA (siRNA)IBA
12/2022 - 09/2012
6Messenger RNA (mRNA)IBA
12/2022 - 04/2005
6Heparitin Sulfate (Heparan Sulfate)IBA
01/2021 - 04/2008
6Endothelins (Endothelin)IBA
08/2010 - 09/2003
5Cadherins (E-Cadherin)IBA
10/2022 - 01/2007
5Endothelin-1 (Endothelin 1)IBA
09/2010 - 09/2003
4Biomarkers (Surrogate Marker)IBA
06/2023 - 07/2014
4Aromatase InhibitorsIBA
01/2022 - 06/2009
4Indicators and Reagents (Reagents)IBA
10/2021 - 07/2003
4Proteins (Proteins, Gene)FDA Link
01/2018 - 03/2005
3ErbB Receptors (EGF Receptor)IBA
09/2023 - 08/2010
3Phenobarbital (Luminal)FDA Link
10/2022 - 09/2012
3CytokinesIBA
05/2022 - 04/2009
3Letrozole (Femara)FDA LinkGeneric
01/2022 - 02/2008
3Selective Estrogen Receptor Modulators (SERM)IBA
01/2022 - 06/2009
3EnzymesIBA
08/2020 - 04/2008
3IntegrinsIBA
01/2015 - 04/2009
3Endothelin A ReceptorIBA
09/2010 - 04/2005
3Estrogen ReceptorsIBA
06/2009 - 09/2003
3Endothelin B ReceptorIBA
04/2004 - 09/2003
2SyndecansIBA
06/2023 - 05/2022
2Thromboplastin (Tissue Factor)IBA
02/2023 - 05/2021
2Progestins (Progestagens)IBA
01/2023 - 02/2009
2Proteoglycans (Proteoglycan)IBA
10/2022 - 04/2008
2Peptide Hydrolases (Proteases)FDA Link
05/2022 - 12/2014
2Paclitaxel (Taxol)FDA LinkGeneric
05/2022 - 06/2010
2Syndecan-3IBA
05/2022 - 12/2009
2RNA-Binding Proteins (RNA-Binding Protein)IBA
03/2022 - 03/2020
2ORALIT (ORS)IBA
01/2022 - 01/2018
2Syndecan-4IBA
10/2021 - 01/2016
2CollagenIBA
01/2021 - 07/2006
2SulfotransferasesIBA
01/2021 - 01/2020
2Testosterone (Sustanon)FDA Link
05/2020 - 11/2009
2Anastrozole (Arimidex)FDA LinkGeneric
01/2018 - 09/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2015 - 04/2004
2AndrogensIBA
02/2015 - 01/2008
2ChemokinesIBA
01/2013 - 04/2009
2Fulvestrant (Faslodex)FDA Link
09/2010 - 06/2009
2Trastuzumab (Herceptin)FDA Link
08/2010 - 03/2006
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2010 - 01/2006
2Estrogen Receptor alphaIBA
06/2009 - 10/2004
2Estrogen Receptor Modulators (Antiestrogen)IBA
06/2009 - 10/2004
2GlycosaminoglycansIBA
03/2009 - 04/2008
2Estradiol (Delestrogen)FDA LinkGeneric
04/2008 - 04/2005
2xylosylprotein 4-beta-galactosyltransferaseIBA
04/2008 - 07/2006
1Plant ExtractsIBA
06/2023
1Phytoestrogens (Phytoestrogen)IBA
06/2023
1Plant Preparations (Preparation, Plant)IBA
06/2023
1ProgesteroneFDA LinkGeneric
01/2023
1Hyaluronan SynthasesIBA
12/2022
1Hyaluronic Acid (Hyaluronan)IBA
12/2022
1rho-Associated KinasesIBA
10/2022
1Extracellular Matrix ProteinsIBA
05/2022

Therapy/Procedure

32Therapeutics
08/2023 - 07/2003
14Drug Therapy (Chemotherapy)
08/2023 - 01/2006
4Radiotherapy
08/2023 - 11/2018
4Hormone Replacement Therapy (Therapy, Hormone Replacement)
06/2023 - 05/2021
3Palliative Care (Palliative Therapy)
02/2022 - 01/2011
3Contraindications
05/2021 - 02/2009
3Neoadjuvant Therapy
07/2014 - 01/2006
2Hormonal Contraception
01/2023 - 02/2009
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
02/2022 - 02/2022
2Brachytherapy
02/2022 - 02/2022
2Adjuvant Radiotherapy
11/2018 - 10/2018
1Salpingo-oophorectomy
06/2023